Due to the potentiality of inducing NF-κB activation and profound inflammatory responses, the clinical usage of TNFα has been limited though it has profound cytotoxic effects on tumor cells (Ashkenazi, 2002). This evidence concerns the gene NFKB1 and neoplasm.